Neuropace Inc (NPCE)

Jan 09, 2025

NeuroPace Inc (NPCE): A New Perspective - Stocks Register

Jan 09, 2025

Jan 09, 2025

NeuroPace Shares Updates on Financial Performance and Board of Directors - Defense World

Jan 09, 2025

Jan 08, 2025

NeuroPace reports preliminary Q4 revenue - MSN

Jan 08, 2025

Jan 08, 2025

NeuroPace Sees Rise in 4Q, Full-Year Sales - MarketWatch

Jan 08, 2025

Jan 08, 2025

NeuroPace Strengthens Board and Reports Strong 2024 Results - TipRanks

Jan 08, 2025

Jan 08, 2025

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates - The Manila Times

Jan 08, 2025

Jan 08, 2025

NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M - TipRanks

Jan 08, 2025

Jan 08, 2025

Neuropace, Inc. Appoints Scott Huennekens to Its Board of Directors - Marketscreener.com

Jan 08, 2025

Jan 08, 2025

NeuroPace Inc (NPCE) Trading Down 5.31% on Jan 8 - GuruFocus.com

Jan 08, 2025

Jan 08, 2025

Institutions profited after NeuroPace, Inc.'s (NASDAQ:NPCE) market cap rose US$37m last week but private equity firms profited the most - Simply Wall St

Jan 08, 2025

Jan 08, 2025

NeuroPace, Inc. (NASDAQ:NPCE) Shares Bought by Barclays PLC - Defense World

Jan 08, 2025

Jan 08, 2025

Geode Capital Management LLC Has $2.21 Million Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jan 08, 2025

Jan 06, 2025

When the Price of (NPCE) Talks, People Listen - Stock Traders Daily

Jan 06, 2025

Jan 06, 2025

Head to Head Analysis: Minerva Surgical (NASDAQ:UTRS) & NeuroPace (NASDAQ:NPCE) - Defense World

Jan 06, 2025

Jan 03, 2025

State Street Corp Increases Stock Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jan 03, 2025

Dec 29, 2024

NeuroPace (NASDAQ:NPCE) versus NEXGEL (NASDAQ:NXGL) Head to Head Contrast - Defense World

Dec 29, 2024

Dec 25, 2024

NeuroPace (NPCE) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Dec 25, 2024

Dec 23, 2024

Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Price Target at $14.50 - Defense World

Dec 23, 2024

Dec 20, 2024

NeuroPace, Inc. (NASDAQ:NPCE) Receives $14.50 Average PT from Analysts - MarketBeat

Dec 20, 2024

Dec 19, 2024

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 19, 2024

Dec 18, 2024

NeuroPace, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - Nasdaq

Dec 18, 2024

Dec 18, 2024

NeuroPace to Present at J.P. Morgan's Prestigious Healthcare Conference in January 2025 - StockTitan

Dec 18, 2024

Dec 17, 2024

NeuroPace (NASDAQ:NPCE) Trading Up 4% – Should You Buy? - Defense World

Dec 17, 2024

Dec 17, 2024

NeuroPace (NASDAQ:NPCE) Price Target Raised to $14.00 - MarketBeat

Dec 17, 2024

Dec 17, 2024

JPMorgan sees NeuroPace stock undervalued, highlights clinically superior RNS device - Investing.com

Dec 17, 2024

Dec 17, 2024

NeuroPace (NASDAQ:NPCE) Trading Up 4%Should You Buy? - MarketBeat

Dec 17, 2024

Dec 17, 2024

NeuroPace's SWOT analysis: epilepsy treatment innovator's stock poised for growth - Investing.com

Dec 17, 2024

Dec 16, 2024

Perspective Therapeutics (NYSE:CATX) vs. NeuroPace (NASDAQ:NPCE) Head to Head Contrast - Defense World

Dec 16, 2024

Dec 16, 2024

Neurostimulation Market is experiencing new opportunities & - openPR

Dec 16, 2024

Dec 15, 2024

NPCENeuropace, Inc. Latest Stock News & Market Updates - StockTitan

Dec 15, 2024

Dec 13, 2024

NeuroPace to Host Investor Day on January 28th in New York City - The Manila Times

Dec 13, 2024

Dec 12, 2024

NeuroPace, Inc. Announces Investor Day to Discuss RNS Technology and Future Plans on January 28, 2025 - Nasdaq

Dec 12, 2024

Dec 12, 2024

NeuroPace Sets Investor Day to Showcase RNS Technology and Growth Strategy in Epilepsy Treatment - StockTitan

Dec 12, 2024

Dec 07, 2024

Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet - MSN

Dec 07, 2024

Dec 05, 2024

How To Trade (NPCE) - Stock Traders Daily

Dec 05, 2024

Dec 05, 2024

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting - The Manila Times

Dec 05, 2024

Dec 04, 2024

NeuroPace's RNS System Shows 82% Seizure Reduction, Featured in 70+ Studies at AES 2024 - StockTitan

Dec 04, 2024

Dec 04, 2024

After Leaping 90% NeuroPace, Inc. (NASDAQ:NPCE) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 04, 2024

Dec 04, 2024

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome - The Manila Times

Dec 04, 2024

Dec 03, 2024

NeuroPace Completes Groundbreaking Trial Enrollment for Severe Epilepsy Treatment Innovation - StockTitan

Dec 03, 2024

Dec 02, 2024

NeuroPace Inc (NPCE) Stock Price Up 7.36% on Dec 2 - GuruFocus.com

Dec 02, 2024

Nov 29, 2024

NeuroPace Inc (NPCE) Shares Up 3.41% on Nov 29 - GuruFocus.com

Nov 29, 2024

Nov 28, 2024

Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) PT at $14.60 - Defense World

Nov 28, 2024

Nov 25, 2024

NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth - Investing.com India

Nov 25, 2024

Nov 25, 2024

NeuroPace, Inc. (NASDAQ:NPCE) Receives $14.60 Average PT from Analysts - MarketBeat

Nov 25, 2024

Nov 21, 2024

NeuroPace, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024

Nov 21, 2024

Top 10 Deep Brain Stimulation Device Companies | Provides Best DevicesMarket.us Media - Market.us Media - United States Market News

Nov 21, 2024

Nov 21, 2024

NeuroPace (NASDAQ:NPCE) versus Cerus (NASDAQ:CERS) Financial Analysis - Defense World

Nov 21, 2024

Nov 20, 2024

NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024

Nov 20, 2024

What Makes NeuroPace (NPCE) a New Buy Stock - MSN

Nov 20, 2024

Nov 18, 2024

Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade - Yahoo Finance

Nov 18, 2024